Stem Cell Transplant Patients Show Long Term ImprovementLiveScience.comby LiveScience Staff An injection of a patient's own stem cells seems to help heal spinal cord injury in the long run, new research suggests. Thirty percent of stem cell therapy…
Turkey's Fourth Face Transplant Patient Wakes upJournal of Turkish WeeklyDr. Murat Yilmaz told AA on Thursday that Turan Colak, who underwent a successful face transplant surgery at Akdeniz University two days ago, woke up yesterday, adding that hi…
NEWARK, Calif. — StemCells, Inc. today announced completion of the first planned interim safety review of the Company's Phase I/II spinal cord injury clinical trial, which indicated that the surgery, …
Multiple myeloma patients are better equipped to halt progression of this blood cancer if treated with lenalidomide, or Revlimid-, following a stem cell transplant, according to a study co-authored by a physician with the Oregon Health & Science Univer…
VANCOUVER, BRITISH COLUMBIA– – RepliCel Life Sciences Inc. is pleased to report that further analysis of results from its successful first-in-man clinical trial revealed substantial hair growth including …
Lenalidomide following stem cell transplant can halt progression of blood cancerNews-Medical.netMultiple myeloma patients are better equipped to halt progression of this blood cancer if treated with lenalidomide, or Revlimid-, following a stem cell tra…
Existing drugs boost new cancer vax responsesFierceVaccinesResearchers at the University of Pennsylvania are looking at using daclizumab (Zenapax)–a monoclonal antibody used to prevent transplant rejection–to target the Tregs and convert them into no…
Spectrum Pharma Begins Phase 2 Study Of ZEVALIN Injection – Quick FactsRTT News(RTTNews) – Spectrum Pharmaceuticals (SPPI: News ) announced the initiation of a Phase 2 study evaluating ZEVALIN Injection for intravenous use + rituximab in combination wi…
The inaugural issue of BioResearch Open Access, a new bimonthly peer-reviewed open access journal, was released today by Mary Ann Liebert, Inc., publishers. The Journal provides a new rapid-publication forum for a broad range of scientific topics inclu…
Remédio usado pós-transplante faz vacina contra câncer ser mais eficazGlobo.com